{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:26:41Z","timestamp":1749947201792,"version":"3.37.3"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Varicella is a highly infectious disease, particularly affecting children, that can lead to complications requiring antibiotics or hospitalization. Antibiotic use for varicella management is poorly documented. This study assessed antibiotic use for varicella and its complications in a pediatric population in England.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Data were drawn from medical records in the Clinical Practice Research Datalink and Hospital Episode Statistics data sets. The study included patients &amp;lt;18 years old with varicella diagnosed during 2014\u20132018 and 3-month follow-up available. We determined varicella-related complications, medication use, healthcare resource utilization, and costs from diagnosis until 3 months after diagnosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 114 578 children with a primary varicella diagnosis. Of these, 7.7% (n = 8814) had a varicella-related complication, the most common being ear, nose, and throat related (37.1% [n = 3271]). In all, 25.9% (n = 29 706 of 114 578) were prescribed antibiotics. A higher proportion of patients with complications than without complications were prescribed antibiotics (64.3% [n = 5668 of 8814] vs 22.7% [n = 24 038 of 105 764]). Mean annualized varicella-related costs were \u00a32 231 481 for the study cohort. Overall, antibiotic prescriptions cost approximately \u00a3262 007.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study highlights high antibiotic use and healthcare resource utilization associated with varicella management, particularly in patients with complications. A national varicella vaccination program in England may reduce varicella burden and related complications, medication use, and costs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad420","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T09:38:24Z","timestamp":1696498704000},"page":"e65-e74","source":"Crossref","is-referenced-by-count":1,"title":["The Clinical and Economic Burden of Antibiotic Use in Pediatric Patients With Varicella Infection: A Retrospective Cohort Analysis of Real-World Data in England"],"prefix":"10.1093","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7915-8553","authenticated-orcid":false,"given":"Stephanie A","family":"Kujawski","sequence":"first","affiliation":[{"name":"Center for Observational and Real-world Evidence, Merck & Co., Inc. , Rahway, New Jersey , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Banks","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Adelphi Real World , Bollington , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline S","family":"Casey","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Adelphi Real World , Bollington , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon B","family":"Drysdale","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, St George\u2019s University Hospitals NHS Foundation Trust , London , United Kingdom"},{"name":"Centre for Neonatal and Paediatric Infection, St George\u2019s, University of London , London , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amisha","family":"Patel","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Adelphi Real World , Bollington , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Massey","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Adelphi Real World , Bollington , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Holbrook","sequence":"additional","affiliation":[{"name":"Real-world Evidence, Adelphi Real World , Bollington , United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjiri","family":"Pawaskar","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-world Evidence, Merck & Co., Inc. , Rahway, New Jersey , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2024072520111415200_jiad420-B1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/INF.0000000000002233","article-title":"Implementing universal varicella vaccination in Europe: the path forward","volume":"38","author":"Spoulou","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2024072520111415200_jiad420-B2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21645515.2018.1546525","article-title":"Global impact of varicella vaccination programs","volume":"15","author":"Varela","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"2024072520111415200_jiad420-B3","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2024072520111415200_jiad420-B4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.vaccine.2014.07.068","article-title":"Varicella and herpes zoster vaccines: WHO position paper, June 2014\u2014recommendations","volume":"34","author":"World Health Organization","year":"2016","journal-title":"Vaccine"},{"key":"2024072520111415200_jiad420-B5","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/infdis\/jiac337","article-title":"Celebrating 25 years of varicella vaccination coverage for children and adolescents in the United States: a success story","volume":"226","author":"Elam-Evans","year":"2022","journal-title":"J Infect Dis"},{"key":"2024072520111415200_jiad420-B6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12879-017-2445-2","article-title":"Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization","volume":"17","author":"Riera-Montes","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2024072520111415200_jiad420-B7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"key":"2024072520111415200_jiad420-B8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/archdischild-2015-308283","article-title":"Varicella paediatric hospitalisations in Belgium: a 1-year national survey","volume":"101","author":"Blumental","year":"2016","journal-title":"Arch Dis Child"},{"key":"2024072520111415200_jiad420-B9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1186\/s12879-021-06848-4","article-title":"Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis","volume":"21","author":"Vandenhaute","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2024072520111415200_jiad420-B10","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1186\/s12889-019-7071-z","article-title":"The use of antibiotics in the treatment of pediatric varicella patients: real-world evidence from the multi-country MARVEL study in Latin America & Europe","volume":"19","author":"Wolfson","year":"2019","journal-title":"BMC Public Health"},{"key":"2024072520111415200_jiad420-B11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/21645515.2018.1559687","article-title":"Varicella healthcare resource utilization in middle income countries: a pooled analysis of the multi-country MARVEL study in Latin America & Europe","volume":"15","author":"Wolfson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"author":"National Institute of Health and Care Excellence (NICE)","key":"2024072520111415200_jiad420-B12"},{"key":"2024072520111415200_jiad420-B13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","article-title":"Can varicella be eliminated by vaccination? potential clinical and economic effects of universal childhood varicella immunisation in Germany","volume":"191","author":"Wutzler","year":"2002","journal-title":"Med Microbiol Immunol"},{"key":"2024072520111415200_jiad420-B14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13052-022-01393-5","article-title":"Assessing the use of antibiotics in pediatric patients hospitalized for varicella","volume":"48","author":"Bozzola","year":"2022","journal-title":"Ital J Pediatr"},{"key":"2024072520111415200_jiad420-B15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.pop.2018.05.006","article-title":"Emergence of global antibiotic resistance","volume":"45","author":"Morehead","year":"2018","journal-title":"Prim Care"},{"key":"2024072520111415200_jiad420-B16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"2024072520111415200_jiad420-B17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/joim.13597","article-title":"Clostridium difficile and other adverse events from overprescribed antibiotics for acute upper respiratory infection","volume":"293","author":"Carmichael","year":"2023","journal-title":"J Intern Med"},{"year":"2022","author":"NHS Digital","key":"2024072520111415200_jiad420-B18"},{"key":"2024072520111415200_jiad420-B19","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"year":"2021","author":"Lopez","key":"2024072520111415200_jiad420-B20"},{"key":"2024072520111415200_jiad420-B21","doi-asserted-by":"crossref","first-page":"1900233","DOI":"10.2807\/1560-7917.ES.2019.24.42.1900233","article-title":"Burden of varicella complications in secondary care, England, 2004 to 2017","volume":"24","author":"Bernal","year":"2019","journal-title":"Euro Surveill"},{"key":"2024072520111415200_jiad420-B22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe\u2014taking the practical approach","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med"},{"key":"2024072520111415200_jiad420-B23","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/adc.2007.123232","article-title":"Severe complications of chickenpox in hospitalised children in the UK and Ireland","volume":"92","author":"Cameron","year":"2007","journal-title":"Arch Dis Child"},{"key":"2024072520111415200_jiad420-B24","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/hpeds.2017-0086","article-title":"Study of complications of varicella-zoster virus infection in hospitalized children at a reference hospital for infectious disease treatment","volume":"8","author":"Diniz","year":"2018","journal-title":"Hosp Pediatr"},{"key":"2024072520111415200_jiad420-B25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/ns2014.04.28.33.52.e8249","article-title":"Varicella zoster virus: chickenpox and shingles","volume":"28","author":"Gould","year":"2014","journal-title":"Nurs Stand"},{"key":"2024072520111415200_jiad420-B26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40121-019-00273-6","article-title":"Specific varicella-related complications and their decrease in hospitalized children after the introduction of general varicella vaccination: results from a multicenter pediatric hospital surveillance study in Bavaria (Germany)","volume":"8","author":"Hagemann","year":"2019","journal-title":"Infect Dis Ther"},{"key":"2024072520111415200_jiad420-B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/INF.0b013e3181586665","article-title":"The burden of varicella complications before the introduction of routine varicella vaccination in Germany","volume":"27","author":"Liese","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"2024072520111415200_jiad420-B28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14760584.2019.1573145","article-title":"Burden of varicella in Central and Eastern Europe: findings from a systematic literature review","volume":"18","author":"M\u00e9szner","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2024072520111415200_jiad420-B29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0000000000001656","article-title":"Varicella-related primary health-care visits, hospitalizations and mortality in Norway, 2008\u20132014","volume":"36","author":"Mirinaviciute","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"2024072520111415200_jiad420-B30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00431-019-03332-9","article-title":"Epidemiological and clinical characteristics and the approach to infant chickenpox in primary care","volume":"178","author":"Rodriguez-Santana","year":"2019","journal-title":"Eur J Pediatr"},{"key":"2024072520111415200_jiad420-B31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/INF.0b013e3181e2817f","article-title":"Complications of varicella after implementation of routine childhood varicella vaccination in Germany","volume":"29","author":"Spackova","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"2024072520111415200_jiad420-B32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00431-005-0043-6","article-title":"Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction","volume":"165","author":"Theodoridou","year":"2006","journal-title":"Eur J Pediatr"},{"key":"2024072520111415200_jiad420-B33","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1016\/j.vaccine.2014.04.034","article-title":"Low varicella-related consultation rate in The Netherlands in primary care data","volume":"32","author":"van Lier","year":"2014","journal-title":"Vaccine"},{"volume-title":"Unit costs of health and social care.","year":"2020","author":"Curtis","key":"2024072520111415200_jiad420-B34"},{"author":"NHS Business Services Authority","key":"2024072520111415200_jiad420-B35"},{"author":"NHS Improvement","key":"2024072520111415200_jiad420-B36"},{"year":"2022","author":"NHS Digital","key":"2024072520111415200_jiad420-B37"},{"key":"2024072520111415200_jiad420-B38","doi-asserted-by":"crossref","first-page":"2151291","DOI":"10.1080\/21645515.2022.2151291","article-title":"Available evidence and potential for vaccines for reduction in antibiotic prescriptions","volume":"18","author":"Gabutti","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2024072520111415200_jiad420-B39","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-2238-4","article-title":"Childhood vaccines and antibiotic use in low- and middle-income countries","volume":"581","author":"Lewnard","year":"2020","journal-title":"Nature"},{"key":"2024072520111415200_jiad420-B40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1473-3099(20)30880-X","article-title":"Impact of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease and pneumonia in The Gambia: 10 years of population-based surveillance","volume":"21","author":"Mackenzie","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024072520111415200_jiad420-B41","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.1073\/pnas.1721095115","article-title":"Impact of existing vaccines in reducing antibiotic resistance: primary and secondary effects","volume":"115","author":"Klugman","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024072520111415200_jiad420-B42","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.aad9358","article-title":"Antibiotic use and its consequences for the normal microbiome","volume":"352","author":"Blaser","year":"2016","journal-title":"Science"},{"key":"2024072520111415200_jiad420-B43","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mayocp.2020.07.019","article-title":"Association of infant antibiotic exposure with childhood health outcomes","volume":"96","author":"Aversa","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"2024072520111415200_jiad420-B44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QCO.0000000000000096","article-title":"Global burden of childhood diarrhea and interventions","volume":"27","author":"Das","year":"2014","journal-title":"Curr Opin Infect Dis"},{"key":"2024072520111415200_jiad420-B45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7861\/clinmedicine.18-3-237","article-title":"Clostridium difficile infection and antibiotic-associated diarrhoea","volume":"18","author":"Mullish","year":"2018","journal-title":"Clin Med (Lond)"},{"key":"2024072520111415200_jiad420-B46","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/vaccines10091416","article-title":"Modeling the impact of exogenous boosting and universal varicella vaccination on the clinical and economic burden of varicella and herpes zoster in a dynamic population for England and Wales","volume":"10","author":"Sharomi","year":"2022","journal-title":"Vaccines"},{"key":"2024072520111415200_jiad420-B47","doi-asserted-by":"crossref","first-page":"S463","DOI":"10.1093\/infdis\/jiac271","article-title":"Health and economic impact of the United States varicella vaccination program, 1996\u20132020","volume":"226","author":"Zhou","year":"2022","journal-title":"J Infect Dis"},{"key":"2024072520111415200_jiad420-B48","doi-asserted-by":"crossref","first-page":"e0269916","DOI":"10.1371\/journal.pone.0269916","article-title":"Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States","volume":"17","author":"Pawaskar","year":"2022","journal-title":"PLoS One"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad420\/52190879\/jiad420.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/e65\/58649345\/jiad420.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/230\/1\/e65\/58649345\/jiad420.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T20:14:56Z","timestamp":1721938496000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/230\/1\/e65\/7289448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2024,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad420","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"type":"print","value":"0022-1899"},{"type":"electronic","value":"1537-6613"}],"subject":[],"published-other":{"date-parts":[[2024,7,15]]},"published":{"date-parts":[[2023,10,5]]}}}